Gardasil replaces Cervarix in immunisation schedule from September 2012

The human papillomavirus (HPV) vaccine used in the National Immunisation Programme will change from Cervarix to Gardasil on 1 September 2012.

HPV vaccination coverage in England is among the highest in the world | SCIENCE PHOTO LIBRARY
HPV vaccination coverage in England is among the highest in the world | SCIENCE PHOTO LIBRARY

Until this time, the Department of Health advises that Cervarix should continue to be used in eligible girls. For courses not completed by the end of the academic year, Cervarix should be used to complete the course in the next school year. It is important that all three doses are given and that the second and third doses are given at least one month apart. Courses should be completed by April 2013, when most Cervarix stock expires.

Increased protection

Gardasil provides protection against HPV types that cause genital warts (types 6 and 11) in addition to those responsible for cervical cancer (16 and 18).

Ordering

Gardasil is expected to be available for ordering via ImmForm in August 2012, although it should not be used until 1 September 2012.

View Cervarix drug record
View Gardasil drug record

Further information:
GlaxoSmithKline
Sanofi Pasteur MSD

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more